U.S. Judge Rejects Breast Cancer Gene Patents
Tuesday, March 30, 2010 - 15:21
in Health & Medicine
The most controversial patents in biotechnology—covering breast cancer genes BRCA1 and BRCA2—were declared invalid...
The most controversial patents in biotechnology—covering breast cancer genes BRCA1 and BRCA2—were declared invalid...